Publications

This plan outlines our compliance and education priorities for 2024-2025.

Read our 2024 stakeholder survey report, which aims to improve the way we work with our stakeholders.

We commissioned the Health Design Lab to conduct market research to better understand the individual consumer, pharmacist and prescriber experiences of shortages and discontinuations.

Read our business plan 2024-25 to find out about our strategic priorities and activities.

Find out how we are managing shortages of medicines and taking action to limit their effects. Read our 2024 report.

Documents released under the FOI Act in the 2023/24 financial year

This Cost Recovery Implementation Statement (CRIS) 2024-2025 provides information on how we implement, and cost recover our regulatory activities.

This framework outlines our processes to identify and manage risk relating to breast implants.

This fact sheet is for healthcare practitioners to help understand the rules surrounding importation of cosmetic injectables.

The report cards show the progress made by the TGA in the 3 strategies that make up the Action Plan for Medical Devices.